GSEA analysis of ccRCC patient tumors suggests that low METTL3 expression levels may be related to some critical biological processes, such as the mTOR pathway, adipogenesis, and reactive oxygen species (ROS), which partially validates the RCC cell line results. Here, METTL3 is linked to renal cell carcinoma.